We are live on
!
Find out more
ZCI
Zevenbergen Capital Investments Portfolio holdings
AUM
$4.38B
1-Year Est. Return
56.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+56.68%
3 Year Est. Return
+239.32%
5 Year Est. Return
+232.55%
10 Year Est. Return
+3,491.87%
AUM
$2.39B
AUM Growth
+$82.4M
(+3.6%)
Cap. Flow
-$209K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
42.21%
Holding
83
New
3
Increased
42
Reduced
24
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$44.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$44.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$36.6M |
| 4 |
Illumina
ILMN
|
+$36.1M |
| 5 |
Baidu
BIDU
|
+$27.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$49.5M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$42.5M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$41.6M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$40.6M |
| 5 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 27.2% |
| 2 | Consumer Discretionary | 26.81% |
| 3 | Healthcare | 15.31% |
| 4 | Financials | 10.32% |
| 5 | Technology | 6.95% |
Similar funds
EQF
SFM
EC
FIS
CFO
CAU
NEI
Zevenbergen Capital Investments's Q1 2015 Portfolio in Review
As of Q1 2015, Zevenbergen Capital Investments held 83 positions worth $2.39B, up 3.6% from $2.31B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Zevenbergen Capital Investments's Q1 2015 filing shows 3 new, 42 increased, 24 reduced and 12 closed positions. Its largest new stake was Illumina: 191,470 shares worth $34.6M. The largest sale was CATAMARAN CORP COM STK (CDA), an estimated $49.5M.
By sector, the portfolio is most concentrated in Communication Services at 27% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Zevenbergen Capital Investments's largest Q1 2015 buy was Illumina: 191,470 shares worth $34.6M.
- Zevenbergen Capital Investments added most to Alexion Pharmaceuticals in Q1 2015, an estimated $44.7M increase.
- Zevenbergen Capital Investments's biggest Q1 2015 reduction was LinkedIn Corporation, cutting an estimated $41.6M.
- Zevenbergen Capital Investments fully exited CATAMARAN CORP COM STK (CDA) in Q1 2015, selling an estimated $49.5M.
- Zevenbergen Capital Investments's ten largest holdings make up 42% of its $2.39B portfolio in Q1 2015.
- Zevenbergen Capital Investments opened 3 new positions and closed 12 in Q1 2015.
- Zevenbergen Capital Investments's portfolio value rose 3.6% quarter-over-quarter to $2.39B.
Based on Zevenbergen Capital Investments's 13F filing for Q1 2015, filed 14 May 2015.